Epstein-Barr virus positive diffuse large B-cell lymphoma predict poor outcome, regardless of the age.
about
New developments in the pathology of malignant lymphoma: a review of the literature published from May 2015–September 2015LMP1+SLAMF1high cells are associated with drug resistance in Epstein-Barr virus-positive Farage cells.Association of risk of non-Hodgkin's lymphoma with hepatitis B virus infection: a meta-analysisWogonin as a targeted therapeutic agent for EBV (+) lymphoma cells involved in LMP1/NF-κB/miR-155/PU.1 pathwayImmunotherapy against cancer-related viruses.EBV-positive diffuse large B-cell lymphoma of the elderly: 2016 update on diagnosis, risk-stratification, and management.The clinical significance of Epstein-Barr virus DNA in peripheral blood mononuclear cells in patients with non-Hodgkin lymphoma.Cytotoxic response against Epstein Barr virus coexists with diffuse large B-cell lymphoma tolerogenic microenvironment: clinical features and survival impact.[Aggressive primary cutaneous B-cell lymphomas and novel EBV+ entities].Response and survival benefit with chemoimmunotherapy in Epstein-Barr virus-positive diffuse large B-cell lymphoma.Whole blood EBV-DNA: A surrogate for immune dysfunction in aggressive lymphoma?Epstein-Barr virus-positive diffuse large B-cell lymphomaOutcomes among US patients with diffuse large B cell lymphoma are independent of tumor Epstein Barr virus positivity or immunosuppression.Alterations in the Rho pathway contribute to Epstein-Barr virus-induced lymphomagenesis in immunosuppressed environments.Sequential occurrence of diffuse large B-cell lymphoma and carcinoma in the nasopharynx: A case report.Primary Gastric EBV-positive Diffuse Large B Cell Lymphoma (DLBCL) of the Elderly with Plasmablastic Differentiation.Clinical characteristics and prognostic significance of EBER positivity in diffuse large B-cell lymphoma: A meta-analysis.Different prevalence and clinical outcome of Epstein-Barr virus positive diffuse large B-cell lymphoma between North American and non-Western populations.Spleen Tyrosine Kinase Inhibitor TAK-659 Prevents Splenomegaly and Tumor Development in a Murine Model of Epstein-Barr Virus-Associated Lymphoma
P2860
Q26774077-257C19DF-4467-4629-9A95-CE8192CBB3AFQ33648588-D3296603-4D57-40EE-AE08-96CFDB953FC9Q35925765-CBF2063D-82DF-45E5-AFD8-3AE258DD7732Q36286889-E7494E4E-C8ED-4384-A8FC-D9389EF92816Q38778924-3ECDAC37-8AB9-44AD-BE36-1963E6E7FAB1Q38812004-A89973AD-FAFA-49C3-A4AC-46CAB7C30BB6Q38901207-A5F81A04-367B-4915-BE57-78CD55769D39Q40052180-E0410305-0488-40C7-82BF-572308FAF566Q40080582-BA92AAF2-091F-43ED-B084-A46F0E9087B8Q40150053-D78F33D2-741A-43D6-A154-BAB2770AFA4AQ41027997-3CCCA38B-92B7-40D8-90CD-0F3AE4A4463DQ41656514-86A71219-D9F9-4E0F-B737-2775D8C192B9Q45324330-4C714A36-BDC1-40D1-9D46-A1AF47657FE8Q50185605-4CCD75D1-541C-461F-95E9-873789DA6CAEQ51738103-14B88E46-5980-476F-B482-C5F3D39890FEQ54267479-A78EA0CB-58BA-4BF8-868F-1B3C8B2F2617Q55426973-39F9BBA8-DDA4-44AF-A8CB-E9682D5B9FB8Q55710335-1F9EF11B-2F65-49EC-880D-27F983DA91EDQ58721423-6C17B96F-43EC-407A-9A97-6DC8F1BA37FC
P2860
Epstein-Barr virus positive diffuse large B-cell lymphoma predict poor outcome, regardless of the age.
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
2015年论文
@zh
2015年论文
@zh-cn
name
Epstein-Barr virus positive di ...... utcome, regardless of the age.
@ast
Epstein-Barr virus positive di ...... utcome, regardless of the age.
@en
type
label
Epstein-Barr virus positive di ...... utcome, regardless of the age.
@ast
Epstein-Barr virus positive di ...... utcome, regardless of the age.
@en
prefLabel
Epstein-Barr virus positive di ...... utcome, regardless of the age.
@ast
Epstein-Barr virus positive di ...... utcome, regardless of the age.
@en
P2093
P2860
P356
P1433
P1476
Epstein-Barr virus positive di ...... utcome, regardless of the age.
@en
P2093
Jian-Yong Li
Jin-Hua Liang
Qi-Xing Gong
Ting-Xun Lu
Xiao-Yan Qu
P2860
P2888
P356
10.1038/SREP12168
P407
P577
2015-07-23T00:00:00Z
P6179
1050416358